Mechanisms of itch in atopic dermatitis

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


Pruritus is a constant and principal symptom of atopic dermatitis (AD), because of it's impact on quality of life. There fore studying of itch mechanisms is actual and could substantiate the ways of AD management. The present review is devoted to consideration of the modern data on this problem.


  1. Российский национальный согласительный документ по атопическому дерматиту. Под ред. Р.М. Хаитова, АА Кубановой. Атопический дерматит: рекомендации для практических врачей. М., «Фармарус Принт», 2000, 242 с.
  2. Бутов Ю.С. Коновка Е.П. Кожный зуд. Леч. Врач, 2003, № 4, с. 24-26.
  3. Феденко Е.С. Симптом кожного зуда при атопическом дерматите. Рос. Аллергол. журн., 2004, № 1, с. 42-44.
  4. Steinhoff M., Bienenstock J., Schmelz M. Neurophysiological, neuroimmunological and neuroendocrine basis of of pruritus. J. Invest. Dermatol. 2006, v. 126, p. 1705-1718.
  5. Schmelz M., Schmid R., Weidner C. Chemical response pattern of different classes of C-nociceptors to pruritogens and algogenes. J. Neurophysiol., 2003, v. 89, p. 2441-2448.
  6. Greaves M.W. Recent advances in pathophysiology and current management of itch. Ann. Acad. Med. Singapore. 2007, v. 36, p. 788-792.
  7. Jinks S.L., Carstens E. Superficial dorsal horn neurons identified by intracutaneous histamine: chemonociceptive responses and modulation by morphine. J. Neurophisiol. 2000, v. 84, p. 616-627.
  8. Grando S.A., Kist D.A., Qui M. Human keratinocytes synthesize, secrete and degrade acetylcholine. J. Invest. Dermatol. 1993, v. 101, p. 32-36.
  9. Paus R., Schmelz M., Biro T. et al. Frontiers in pruritis research: scratching the brain for more effective itch therapy. J. Clin. Invest. 2006. v. 116, p. 1174-1185.
  10. Advenier C., Devillier P. Neurokinins and the skin. J. Allerg. Immunol. (Paris). 1993. v. 25, p. 280-282.
  11. Heyer G., Vogelgsang M., Hornstein O. Acetylcholine is an inducer of itching in patients with atopic eczema. J. Dermatol., 1997, v. 24, p. 621-662.
  12. Kaji A., Shigematsu H., Fujita K. et al. Parasympathetic innervation of cutaneous blood vessels by vasoactive intestinal polypeptide-imm unoreactive and acetylcholinesterase-positive nerves: histochemical and experimental study on rat lower lip. J. Neuroscience, 1988. v. 25, p. 353.
  13. Slominski A., Wortsman J. Neuroendocrinology of the skin. Endocr. Rev. 2000, v. 21, p. 457-487.
  14. Tobin D., Nabarro G., de la Falle H.B. et al. Increased number of immunoreactive nerve fibers in atopic dermatitis. J. Allergy. Clin. Immunol. 1992, v. 90, p. 613-622.
  15. Sugiura H., Omoto M., Hirota Y. et al. Density and fine stricture of peripheral nerves in various skin lesions at atopic dermatitis. Arch. Dermatol. Res. 1997, v. 289, p. 125-131.
  16. Urashima R., Mihara M. Cutaneous nerves in atopic dermatitis. A Histological, immunohistochemical and electron microscopic study. Virchows. Arch. 1998, v. 432, p. 363-370.
  17. Steinhoff M., Corvera C.U., Thoma M.S. et al. Proteinase- activated receptor-2 in human skin: tissue distribution and activation of ceratinocytes by mast cell tryptase. Exp. Dermatol. 1999, v. 8, p. 282-294.
  18. Pincelli C., Sevignani C., Manfredini R. et al. Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J. Invest. Dermatol. 1994, v. 103, p. 13-18.
  19. Pincelli C., Fantini F., Girolomoni G. et al. Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study. Br. J. Dermatol. 1990, v. 122, p. 745-750.
  20. Andrew D., Craig A.D. Spinothalamic lamina I neurons selectively responsive to cutaneous warming in cats. J. Phisiol. 2001, v. 537, p. 489-495.
  21. Darsow U. Processing of histamine-induced itch in the human cerebral cortex: a correlation analysis with dermal reactions. J. Invest. Dermatol. 2000, v. 115. p. 1029-1033.
  22. Johnson H.H., DeOreo G.a., Lanscheid W.P et al. Skin histamine levels in chronic atopic dermatitis. J. Invest. Dermatol. 1960, v. 34, p. 237-238.
  23. Juhlin L. Localization and content of histamine in normal and diseased skin. Acta Dermatol. Venereol. (Stockh), 1987, v. 47, p. 383-391.
  24. Гущин И.С. Аллергическое воспаление и его фармакологический контроль. М., «Фармарус Принт», 1998, 251 с.
  25. Lippert U., Artuc M., Grutzkau A. et al. Human skin mast cells express H2 and H4, but not H3 receptors. J. Invest. Dermatol. 2004, v. 123, p. 116-123.
  26. Rukwied R., Lischeizki G., VcGlone F. et al. Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study. Br. J. Dermatol. 2000, v. 142, p. 114-1120.
  27. Heyer G.R., Hornstein O.P., Handwerker H.O. Reactions to intradermally injected substance P and topically applied mustard oil in atopic dermatitis patients. Acta Dermatol. Venerol. (Stockh). 1991, v. 71, p. 291-295.
  28. Heyer G. Abnormal cutaneous neurosensitivity in atopic skin. Acta Dermatol. Venerol. (Stockh). 1992, v. 176 (suppl), p. 93-94.
  29. Rukwied R., Heyer G. Cutaneous reaction and sensations after intracutaneous injection of vasoactive intestinal polypeptide and acetylcholine in atopic eczema patients and healthy controls. Arch. Dermatol. Res. 1998, v. 290, p. 198-204.
  30. Wahlgren C.F. Measurement of itch. Semin. Dermatol. 1995, v. 14, p. 284.
  31. Giannetti A., Fantini F., Cimitan A. et al. Vasoactive interstinal polypeptide and substance P in the pathogenesis of atopic dermatitis. Acta Dermatol. Venereol. (Stockh). 1992, v. 176 (suppl), p. 90-92.
  32. Walker K., Perkins M., Dray A. Kinins and kinin receptors in the nervous system. Neurochem Int. 1999, v. 26, p. 1-17.
  33. Averberk B., Reeh P.W. Interactions of inflammatory mediators stimulating release of calcitonin gene-related peptide, substance P and prostaglandin E(2) from isolated rat skin. Neuropharmacology. 2001, v. 40, p. 416-423.
  34. Hagermark O. Peripheral and central mediators of itch. Skin Pharmacol. 1992, v. 5, p. 1-8.
  35. Weisshaar E., Ziethen B., Gollnick H. Can serotonin type 3 (5-HT3) receptor antagonist reduce experimentally-induced itch? Inflamm. Res. 1997, v. 46, p. 412-416.
  36. Shelley W., Arthur R. The neurophysiology and neurophysiology of the itch sensation in man. Arch. Dermatol. 1957, v. 76, p. 296-323.
  37. Hagermark O., Rajka G., Bergvist U. Experimental itch in human skin elicited by rat mast cell chymase. Acta Dermatol. Venerol. 1972, v. 52, p. 125-128.
  38. Jarvikallio A., Naukkarinen A., Harvima I.T. et al. Quantitative analysis of tryptase and chymase-containing mast cells in atopic dermatitis and nummular eczema. Br. J. Dermatol. 1997, v. 36, p. 871-877.
  39. Damsgaard T.E., Olsen A.B., Sorensen F.B. et al. Mast cells and atopic dermatitis. Stereological quantification of mast cells in atopic dermatitis and normal human skin. Arch. Dermatol. Res. 1997, v. 289, p. 256-260.
  40. Gasparia.A., Lotze M.T., Rosenberg S.A. et al. Dermatologic changes associated with interleukin-2 administration. JAMA, 1987, v. 258, p. 1624-1629.
  41. Wahlgren C.F., Scheynius A., Hagermark O. Antipruritic effect of oral cyclosporine A in atopic dermatitis. Acta Dermatol., Venereol. (Stockh), 1990, v. 70, p. 323-329.
  42. Wahlgren C.F., Tengvall Linder M., Hagermark O. et al. Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects. Arch. Dermatol. Res. 1995, v. 287, p. 572-580.
  43. Lipperi U., Hoer A., Moller A. et al. Role of antigen-induced cytokine released in atopic pruritus. Int. Arch. Allergy. Immunol. 1998, v. 116, p. 36-39.
  44. Johansonn O., Liang Y., Emtestam L. Increased nerve growth factor-and tyrosine kinase A-like immunoreactivities on prurigo nodularis skin: an exploration of the cause of neurohyperplasia. Arch. Dermatol. 2002, v. 147, p. 71-79.
  45. Grewe M., Vogelsang K., Ruzicka T. et al. Neurotrophin-4-production by human epidermal keratinocytes: increased expression in atopic dermatitis. J. Invest. Dermatol. 2000, v. 114, p. 1108-1112.
  46. Bigliardi P.L., Stammer H., Jost G. et al. Treatment of pruritus with topically applied opiate receptor antagonist. J. Am. Acad. Dermatol. 2007, v. 56, p. 978-988.
  47. Dvorak M., Watkinson A., McGlone F. et al. Histamine induced responses are attenuated by cannabinoid receptor agonist in human skin. Inflamm. Res. 2003, v. 52, p. 238-245.
  48. Velaquez J.R., Lacy P., Moqbel R. Replenishment of RANTES mRNA expression in activated eosinophilis from atopic dermatitis. Immunology. 2000, v. 99, p. 591-599.
  49. Scott A. Acetylcholine in normal and disease skin. Br. J. Dermatol. 1962, v. 74, p. 317-322.
  50. Гущин И.С. Холинергическая система и особенности фармакологического вмешательства в нее некоторых антагонистов Н1-рецепторов. Рос. Аллергол. журн., 2005, № 6, с. 3-16.
  51. Standler S., Stenfonhoff M. Pathophysiology of pruritus in atopic dermatitis: an overview. Exp. Dermatol. 2002, v. 11, p. 12-24.
  52. Гребенченко Е.И., Гущин И.С., Феденко Е.С. Кожная чувствительность к ацетилхолину у больных атопическим дерматитом и поллинозом. Рос. Аллергол. журн. 2008, № 1, с. 19-23.
  53. Andoh T., Yageta Y., Takeshima H. et al. Intradermal nociceptin elicits itch-associated responses through leukotriene B (4) in mice. J. Invest. Dermatol. 2004, v. 123, p. 196-201.
  54. Bienenstock J., Tomioka M., Matsuda H. et al. The role of mast cells in inflammatory processes: evidence for nerve/ mast cells interactions. Int. Arch. Allergy Appl. Immunol., 1987, v, 82, p. 238-243.
  55. Biro T., Acs G., Acs P. et al. Recent advances in understanding of vanilloid receptor: a therapeutic target for treatment of pain and inflammation in skin. J. Investig. Dermat. 1997, v. 2, p. 56-60.
  56. Jemec G.B.E., Wulf H.C. Patient-physician consensus on quality of life in dermatology. Clin. Exp. Dermatol. 1996, v. 21, p. 177-179.
  57. Ray N.J., Jones A.J., Keen P. Morphine, but not sodium cromoglycate, modulates the release of substance P from capsaisin-sensitive neurons in the rat trachea in vitro. Br. J. Pharmacol. 1999, v. 102, p. 797-800.
  58. Schnyder U.W. Neurodermatitis vom klinisch dermatologischen Standpunkt. Acta Allergol. 1961, v. 16, p. 463-474.

Copyright © Pharmarus Print Media, 2009

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies